Slate Path Capital LP

Insider Reports History

Entity
Company
Location
717 5 Th Avenue, 16 Th Fl., New York, NY
Signature
Slate Path Capital LP, By: Jades GP, LLC, its General Partner, By: /s/ John Metzner, its Chief Operating Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Slate Path Capital LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclerion Therapeutics, Inc. 10%+ Owner Common Stock, no par value 0 $0 $1.55 Nov 21, 2024 Indirect

Insider Reports Filed by Slate Path Capital LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCN Cyclerion Therapeutics, Inc. Nov 21, 2024 1 -$555K 4 Nov 25, 2024 10%+ Owner
CYCN Cyclerion Therapeutics, Inc. Jun 3, 2021 1 $3M 4 Jun 7, 2021 10%+ Owner